Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 68

1.

Genomic Analyses of >3,100 Nasopharyngeal Pneumococci Revealed Significant Differences Between Pneumococci Recovered in Four Different Geographical Regions.

van Tonder AJ, Bray JE, Jolley KA, Jansen van Rensburg M, Quirk SJ, Haraldsson G, Maiden MCJ, Bentley SD, Haraldsson Á, Erlendsdóttir H, Kristinsson KG, Brueggemann AB.

Front Microbiol. 2019 Feb 25;10:317. doi: 10.3389/fmicb.2019.00317. eCollection 2019.

2.

Vaccination of Icelandic Children with the 10-Valent Pneumococcal Vaccine Leads to a Significant Herd Effect among Adults in Iceland.

Quirk SJ, Haraldsson G, Hjálmarsdóttir MÁ, van Tonder AJ, Hrafnkelsson B, Bentley SD, Haraldsson Á, Erlendsdóttir H, Brueggemann AB, Kristinsson KG.

J Clin Microbiol. 2019 Mar 28;57(4). pii: e01766-18. doi: 10.1128/JCM.01766-18. Print 2019 Apr.

3.

Effect of Vaccination on Pneumococci Isolated from the Nasopharynx of Healthy Children and the Middle Ear of Children with Otitis Media in Iceland.

Quirk SJ, Haraldsson G, Erlendsdóttir H, Hjálmarsdóttir MÁ, van Tonder AJ, Hrafnkelsson B, Sigurdsson S, Bentley SD, Haraldsson Á, Brueggemann AB, Kristinsson KG.

J Clin Microbiol. 2018 Nov 27;56(12). pii: e01046-18. doi: 10.1128/JCM.01046-18. Print 2018 Dec.

4.

Genome Sequencing Reveals a Large and Diverse Repertoire of Antimicrobial Peptides.

Rezaei Javan R, van Tonder AJ, King JP, Harrold CL, Brueggemann AB.

Front Microbiol. 2018 Aug 27;9:2012. doi: 10.3389/fmicb.2018.02012. eCollection 2018.

5.

Diverse Streptococcus pneumoniae Strains Drive a Mucosal-Associated Invariant T-Cell Response Through Major Histocompatibility Complex class I-Related Molecule-Dependent and Cytokine-Driven Pathways.

Kurioka A, van Wilgenburg B, Javan RR, Hoyle R, van Tonder AJ, Harrold CL, Leng T, Howson LJ, Shepherd D, Cerundolo V, Brueggemann AB, Klenerman P.

J Infect Dis. 2018 Mar 5;217(6):988-999. doi: 10.1093/infdis/jix647.

6.

Pneumococcal prophages are diverse, but not without structure or history.

Brueggemann AB, Harrold CL, Rezaei Javan R, van Tonder AJ, McDonnell AJ, Edwards BA.

Sci Rep. 2017 Feb 20;7:42976. doi: 10.1038/srep42976.

7.

Putatively novel serotypes and the potential for reduced vaccine effectiveness: capsular locus diversity revealed among 5405 pneumococcal genomes.

van Tonder AJ, Bray JE, Quirk SJ, Haraldsson G, Jolley KA, Maiden MCJ, Hoffmann S, Bentley SD, Haraldsson Á, Erlendsdóttir H, Kristinsson KG, Brueggemann AB.

Microb Genom. 2016 Oct 1;2(10):000090. doi: 10.1099/mgen.0.000090.

8.

Correction for van Tonder et al., Genomics Reveals the Worldwide Distribution of Multidrug-Resistant Serotype 6E Pneumococci.

van Tonder AJ, Bray JE, Roalfe L, White R, Zancolli M, Quirk SJ, Haraldsson G, Jolley KA, Maiden MCJ, Bentley SD, Haraldsson Á, Erlendsdóttir H, Kristinsson KG, Goldblatt D, Brueggemann AB.

J Clin Microbiol. 2016 Jun;54(6):1670. doi: 10.1128/JCM.00619-16. No abstract available.

9.

Genomic analyses of pneumococci reveal a wide diversity of bacteriocins - including pneumocyclicin, a novel circular bacteriocin.

Bogaardt C, van Tonder AJ, Brueggemann AB.

BMC Genomics. 2015 Jul 28;16:554. doi: 10.1186/s12864-015-1729-4.

10.

Genomics Reveals the Worldwide Distribution of Multidrug-Resistant Serotype 6E Pneumococci.

van Tonder AJ, Bray JE, Roalfe L, White R, Zancolli M, Quirk SJ, Haraldsson G, Jolley KA, Maiden MC, Bentley SD, Haraldsson Á, Erlendsdóttir H, Kristinsson KG, Goldblatt D, Brueggemann AB.

J Clin Microbiol. 2015 Jul;53(7):2271-85. doi: 10.1128/JCM.00744-15. Epub 2015 May 13. Erratum in: J Clin Microbiol. 2016 Jun;54(6):1670.

11.

Defining the estimated core genome of bacterial populations using a Bayesian decision model.

van Tonder AJ, Mistry S, Bray JE, Hill DM, Cody AJ, Farmer CL, Klugman KP, von Gottberg A, Bentley SD, Parkhill J, Jolley KA, Maiden MC, Brueggemann AB.

PLoS Comput Biol. 2014 Aug 21;10(8):e1003788. doi: 10.1371/journal.pcbi.1003788. eCollection 2014 Aug.

12.

Streptococcus pneumoniae carriage prevalence in Nepal: evaluation of a method for delayed transport of samples from remote regions and implications for vaccine implementation.

Hanieh S, Hamaluba M, Kelly DF, Metz JA, Wyres KL, Fisher R, Pradhan R, Shakya D, Shrestha L, Shrestha A, Joshi A, Habens J, Maharjan BD, Thorson S, Bohler E, Yu LM, Kelly S, Plested E, John T, Werno AM, Adhikari N, Murdoch DR, Brueggemann AB, Pollard AJ.

PLoS One. 2014 Jun 6;9(6):e98739. doi: 10.1371/journal.pone.0098739. eCollection 2014.

13.

Evolution and genetic diversity of the Spain23F-ST81 clone causing adult invasive pneumococcal disease in Barcelona (1990-2012).

Domenech A, Ardanuy C, Grau I, Calatayud L, Pallares R, Fenoll A, Brueggemann AB, Liñares J.

J Antimicrob Chemother. 2014 Apr;69(4):924-31. doi: 10.1093/jac/dkt473. Epub 2013 Dec 8.

14.

Population genetic structure of Streptococcus pneumoniae in Kilifi, Kenya, prior to the introduction of pneumococcal conjugate vaccine.

Brueggemann AB, Muroki BM, Kulohoma BW, Karani A, Wanjiru E, Morpeth S, Kamau T, Sharif S, Scott JA.

PLoS One. 2013 Nov 25;8(11):e81539. doi: 10.1371/journal.pone.0081539. eCollection 2013.

15.

Evidence of antimicrobial resistance-conferring genetic elements among pneumococci isolated prior to 1974.

Wyres KL, van Tonder A, Lambertsen LM, Hakenbeck R, Parkhill J, Bentley SD, Brueggemann AB.

BMC Genomics. 2013 Jul 24;14:500. doi: 10.1186/1471-2164-14-500.

16.

Pneumococcal capsular switching: a historical perspective.

Wyres KL, Lambertsen LM, Croucher NJ, McGee L, von Gottberg A, Liñares J, Jacobs MR, Kristinsson KG, Beall BW, Klugman KP, Parkhill J, Hakenbeck R, Bentley SD, Brueggemann AB.

J Infect Dis. 2013 Feb 1;207(3):439-49. doi: 10.1093/infdis/jis703. Epub 2012 Nov 21. Erratum in: J Infect Dis. 2013 Oct 1;208(7):1187.

17.

The multidrug-resistant PMEN1 pneumococcus is a paradigm for genetic success.

Wyres KL, Lambertsen LM, Croucher NJ, McGee L, von Gottberg A, Liñares J, Jacobs MR, Kristinsson KG, Beall BW, Klugman KP, Parkhill J, Hakenbeck R, Bentley SD, Brueggemann AB.

Genome Biol. 2012 Nov 16;13(11):R103. doi: 10.1186/gb-2012-13-11-r103.

18.

Pneumococci can persistently colonize adult patients with chronic respiratory disease.

Domenech A, Ardanuy C, Balsalobre L, Marti S, Calatayud L, De la Campa AG, Brueggemann AB, Liñares J.

J Clin Microbiol. 2012 Dec;50(12):4047-53. doi: 10.1128/JCM.02056-12. Epub 2012 Oct 10.

19.

Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event.

Golubchik T, Brueggemann AB, Street T, Gertz RE Jr, Spencer CC, Ho T, Giannoulatou E, Link-Gelles R, Harding RM, Beall B, Peto TE, Moore MR, Donnelly P, Crook DW, Bowden R.

Nat Genet. 2012 Jan 29;44(3):352-5. doi: 10.1038/ng.1072.

20.

Molecular typing methods for outbreak detection and surveillance of invasive disease caused by Neisseria meningitidis, Haemophilus influenzae and Streptococcus pneumoniae, a review.

Harrison OB, Brueggemann AB, Caugant DA, van der Ende A, Frosch M, Gray S, Heuberger S, Krizova P, Olcen P, Slack M, Taha MK, Maiden MC.

Microbiology. 2011 Aug;157(Pt 8):2181-95. doi: 10.1099/mic.0.050518-0. Epub 2011 May 26. Review.

21.

Shifting genetic structure of invasive serotype 19A pneumococci in the United States.

Beall BW, Gertz RE, Hulkower RL, Whitney CG, Moore MR, Brueggemann AB.

J Infect Dis. 2011 May 15;203(10):1360-8. doi: 10.1093/infdis/jir052. Epub 2011 Mar 11.

22.

Pediatric parapneumonic empyema, Spain.

Obando I, Muñoz-Almagro C, Arroyo LA, Tarrago D, Sanchez-Tatay D, Moreno-Perez D, Dhillon SS, Esteva C, Hernandez-Bou S, Garcia-Garcia JJ, Hausdorff WP, Brueggemann AB.

Emerg Infect Dis. 2008 Sep;14(9):1390-7. doi: 10.3201/eid1409.071094.

23.

Antibiotic susceptibility and molecular epidemiology of nasopharyngeal pneumococci from Spanish children.

Sánchez-Tatay D, Arroyo LA, Tarragó D, Lirola MJ, Porras A, Fenoll A, Hausdorff WP, Brueggemann AB, Obando I.

Clin Microbiol Infect. 2008 Aug;14(8):797-801. doi: 10.1111/j.1469-0691.2008.02025.x.

24.

Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005.

Moore MR, Gertz RE Jr, Woodbury RL, Barkocy-Gallagher GA, Schaffner W, Lexau C, Gershman K, Reingold A, Farley M, Harrison LH, Hadler JL, Bennett NM, Thomas AR, McGee L, Pilishvili T, Brueggemann AB, Whitney CG, Jorgensen JH, Beall B.

J Infect Dis. 2008 Apr 1;197(7):1016-27. doi: 10.1086/528996.

PMID:
18419539
25.

Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, England.

Foster D, Knox K, Walker AS, Griffiths DT, Moore H, Haworth E, Peto T, Brueggemann AB, Crook DW; Oxford Invasive Pneumococcal Surveillance Group.

J Med Microbiol. 2008 Apr;57(Pt 4):480-7. doi: 10.1099/jmm.0.47690-0.

PMID:
18349369
26.

Vaccine escape recombinants emerge after pneumococcal vaccination in the United States.

Brueggemann AB, Pai R, Crook DW, Beall B.

PLoS Pathog. 2007 Nov;3(11):e168.

27.

Presence of nonhemolytic pneumolysin in serotypes of Streptococcus pneumoniae associated with disease outbreaks.

Jefferies JM, Johnston CH, Kirkham LA, Cowan GJ, Ross KS, Smith A, Clarke SC, Brueggemann AB, George RC, Pichon B, Pluschke G, Pfluger V, Mitchell TJ.

J Infect Dis. 2007 Sep 15;196(6):936-44. Epub 2007 Aug 6.

PMID:
17703426
28.

Effect of antibiotic prescribing on antibiotic resistance in individual children in primary care: prospective cohort study.

Chung A, Perera R, Brueggemann AB, Elamin AE, Harnden A, Mayon-White R, Smith S, Crook DW, Mant D.

BMJ. 2007 Sep 1;335(7617):429. Epub 2007 Jul 26.

29.

Molecular epidemiology of paediatric invasive pneumococcal disease in southern Spain after the introduction of heptavalent pneumococcal conjugate vaccine.

Obando I, Arroyo LA, Sánchez-Tatay D, Tarragó D, Moreno D, Hausdorff WP, Brueggemann AB.

Clin Microbiol Infect. 2007 Mar;13(3):347-8. No abstract available.

30.

Respiratory infections for which general practitioners consider prescribing an antibiotic: a prospective study.

Harnden A, Perera R, Brueggemann AB, Mayon-White R, Crook DW, Thomson A, Mant D.

Arch Dis Child. 2007 Jul;92(7):594-7. Epub 2007 Mar 16.

31.

Antibiotic resistance mechanisms among pediatric respiratory and enteric pathogens: A current update.

Brueggemann AB.

Pediatr Infect Dis J. 2006 Oct;25(10):969-73. Review.

PMID:
17006308
32.

Molecular typing of pneumococci causing parapneumonic empyema in Spanish children using multilocus sequence typing directly on pleural fluid samples.

Obando I, Arroyo LA, Sánchez-Tatay D, Moreno D, Hausdorff WP, Brueggemann AB.

Pediatr Infect Dis J. 2006 Oct;25(10):962-3. No abstract available.

PMID:
17006306
33.

Whooping cough in school age children with persistent cough: prospective cohort study in primary care.

Harnden A, Grant C, Harrison T, Perera R, Brueggemann AB, Mayon-White R, Mant D.

BMJ. 2006 Jul 22;333(7560):174-7. Epub 2006 Jul 7.

34.

Epidemiology of methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus in a rural state.

Polgreen PM, Beekmann SE, Chen YY, Doern GV, Pfaller MA, Brueggemann AB, Herwaldt LA, Diekema DJ.

Infect Control Hosp Epidemiol. 2006 Mar;27(3):252-6. Epub 2006 Feb 28.

PMID:
16532412
35.

Chloramphenicol treatment for acute infective conjunctivitis in children in primary care: a randomised double-blind placebo-controlled trial.

Rose PW, Harnden A, Brueggemann AB, Perera R, Sheikh A, Crook D, Mant D.

Lancet. 2005 Jul 2-8;366(9479):37-43.

PMID:
15993231
36.

Temporal and geographic stability of the serogroup-specific invasive disease potential of Streptococcus pneumoniae in children.

Brueggemann AB, Peto TE, Crook DW, Butler JC, Kristinsson KG, Spratt BG.

J Infect Dis. 2004 Oct 1;190(7):1203-11. Epub 2004 Aug 25.

PMID:
15346329
37.

Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates.

Brueggemann AB, Spratt BG.

J Clin Microbiol. 2003 Nov;41(11):4966-70.

38.

Characterization of German penicillin non-susceptible serotype 23F pneumococci using multilocus sequence typing.

Reinert RR, Muckel S, Al-Lahham A, Spratt BG, Brueggemann AB, Hakenbeck R, Lütticken R.

J Med Microbiol. 2003 Nov;52(Pt 11):981-7.

PMID:
14532343
39.

Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential.

Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG.

J Infect Dis. 2003 May 1;187(9):1424-32. Epub 2003 Apr 4.

PMID:
12717624
40.

Stability of serotypes during nasopharyngeal carriage of Streptococcus pneumoniae.

Meats E, Brueggemann AB, Enright MC, Sleeman K, Griffiths DT, Crook DW, Spratt BG.

J Clin Microbiol. 2003 Jan;41(1):386-92.

41.

Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study.

Diekema DJ, Messer SA, Brueggemann AB, Coffman SL, Doern GV, Herwaldt LA, Pfaller MA.

J Clin Microbiol. 2002 Apr;40(4):1298-302.

42.

Liquid ventilation with perflubron in the treatment of rats with pneumococcal pneumonia.

Dickson EW, Heard SO, Tarara TE, Weers JG, Brueggemann AB, Doern GV.

Crit Care Med. 2002 Feb;30(2):393-5.

PMID:
11889317
43.

Fluoroquinolone resistance in Streptococcus pneumoniae in United States since 1994-1995.

Brueggemann AB, Coffman SL, Rhomberg P, Huynh H, Almer L, Nilius A, Flamm R, Doern GV.

Antimicrob Agents Chemother. 2002 Mar;46(3):680-8.

44.

The molecular epidemiology of penicillin-resistant Streptococcus pneumoniae in the United States, 1994-2000.

Richter SS, Heilmann KP, Coffman SL, Huynh HK, Brueggemann AB, Pfaller MA, Doern GV.

Clin Infect Dis. 2002 Feb 1;34(3):330-9. Epub 2001 Dec 17.

PMID:
11774080
45.

Antimicrobial resistance among clinical isolates of Streptococcus pneumoniae in the United States during 1999--2000, including a comparison of resistance rates since 1994--1995.

Doern GV, Heilmann KP, Huynh HK, Rhomberg PR, Coffman SL, Brueggemann AB.

Antimicrob Agents Chemother. 2001 Jun;45(6):1721-9.

46.
47.

Roundtable discussion. Optimizing the use of antimicrobial therapy.

Bishai W, Brueggemann AB, Nicolau DP, Steinberg I, Spiritus E, Tanigawa C, Koenig S, Chaisson RE, Browne BA, Yoder DM.

Am J Manag Care. 2000 Dec;6(23 Suppl):S1222-35. No abstract available.

48.

Resistance among Streptococcus pneumoniae: patterns, mechanisms, interpreting the breakpoints.

Brueggemann AB, Doern GV.

Am J Manag Care. 2000 Dec;6(23 Suppl):S1189-96. Review.

49.
50.

Antimicrobial-drug use and changes in resistance in Streptococcus pneumoniae.

Diekema DJ, Brueggemann AB, Doern GV.

Emerg Infect Dis. 2000 Sep-Oct;6(5):552-6.

Supplemental Content

Loading ...
Support Center